Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Marble Ridge Capital, Starboard Value, Cadence Bancorp (CADE), R C M Technologies Inc (RCMT), and More

The Executive Chairman & President of Rcm Technologies (NASDAQ: RCMT) is Buying Shares (AnalystRatings)
Yesterday, the Executive Chairman & President of RCM Technologies (RCMT), Bradley Vizi, bought shares of RCMT for $2.5M. This recent transaction increases Bradley Vizi’s holding in the company by 26.48% to a total of $12.17 million. This is Vizi’s first transaction since reporting a Buy transaction on FSTR back in March 2017.

Tuesday 3/19 Insider Buying Report: CADE, IBKC (Nasdaq.com)
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. At Cadence Bancorporation, a filing with the SEC revealed that on Friday, CEO Paul B. Murphy Jr. bought 50,000 shares of CADE, for a cost of $19.93 each, for a total investment of $996,438. Murphy Jr. was up about 4.0% on the purchase at the high point of today’s trading session, with CADE trading as high as $20.73 at last check today. Cadence Bancorporation is trading up about 0.7% on the day Tuesday. This buy marks the first one filed by Murphy Jr. in the past twelve months.

Singapore is Harbouring a Suspect Wanted in Massive Trading Scam, Says Sri Lanka (TheOnlineCitizen)
Sri Lankan President Maithripala Sirisena has accused Singapore of harbouring one of Sri Lanka’s former central bank chiefs who is wanted in connection with a S$74 million insider trading the scam. Arjuna Mahendran, a Singapore national born in Sri Lanka, was accused in 2015 of passing sensitive information to his bond-dealer son-in-low to pocket millions. The two of them are accused of manipulating bond auctions in 2015 and 2016, causing the state of Sri Lanka lossess amounting to over $11 million.

Insider trading: March 19, 2019 (BIV.com)
The following is a list of stock trades made by corporate executives, directors and other company insiders of B.C.’s public companies filed in the week ended March 13, 2019. The information comes from a compilation of required reports filed with the BC Securities Commission obtained from DisclosureNet.com. Insider Amir Javidan, officer. Company: Well Health Technologies Corp. (TSX-V:WELL). Shares owned: 2,473,913. Trade date: March 7. Trade total: $1,000,000. Trade: Acquisition of 2,173,913 shares at a price of $0.46 per share.

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 40,000 shares of Stock (MarketExclusive)
Insider Trading Activity For Opko Health Inc. (NASDAQ:OPK): Phillip Md Et Al Frost , CEO of Opko Health Inc. (NASDAQ:OPK) reportedly Bought 40,000 shares of the company’s stock at an average price of 2.47 for a total transaction amount of $98,800.00.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...